How to Buy Emergent Biosolutions Stock
Emergent Biosolutions Inc
Emergent Biosolutions is a pharmaceutical company located in Maryland, United States, which is part of the Healthcare sector, and is traded under the ticker EBS on the NYSE exchange.
Emergent Biosolutions stock last closed at $11.54, down 1.45% from the previous day, and has increased 10.01% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.39 percentage points. Emergent Biosolutions stock is currently +187.06% from its 52-week low of $4.02, and -17.92% from its 52-week high of $14.06.
There are currently 52.52M EBS shares outstanding. The market value of EBS is $606.08M. In the past 24 hours, 681,000 EBS shares were traded.
How to Buy Emergent Biosolutions Stock
Not sure how to invest in Emergent Biosolutions stock? Here's how.
- Figure out where to buy Emergent Biosolutions stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Emergent Biosolutions stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your method of payment and add your info.
- Evaluate Emergent Biosolutions stock: The Emergent Biosolutions ticker symbol is EBS. Is Emergent Biosolutions stock a good investment? Should you buy shares of EBS? How do EBS's underlying business fundamentals look? Do top analysts think Emergent Biosolutions is a good buy? Why has EBS's stock price moved recently? (Hint: Our stock research website can help you evaluate if EBS is a good stock to buy).
- Place your EBS purchase: Decide if you will purchase EBS shares at the current market price or use a limit order to buy EBS stock at a particular price.
- Watch your investment in EBS: Create a watchlist to watch your investment in Emergent Biosolutions stock.
Step 1: Figure out where to buy Emergent Biosolutions stock
You will need an online brokerage account to access the NYSE market and buy EBS shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal information so you can invest in EBS stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new trading account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on the best app for stock investing, you need to deposit funds:
Check out the video below to see the process of transferring funds into your brokerage account.
Step 4: Evaluate Emergent Biosolutions stock
Once you have selected the best place to buy Emergent Biosolutions stock, it's absolutely critical to evaluate their stock before you invest, so you truly comprehend the risk and upside.
Emergent Biosolutions shares data
Emergent Biosolutions Overview
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on EBS's stock page.
Is EBS stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge EBS's true value.
Using relative valuations measures:
- EBS may be undervalued based on its P/E ratio of 8.13x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of -129.87x
- EBS may be undervalued based on its P/B ratio of 1.04x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.71x
You can access additional valuation research on EBS's stock here.
EBS Financial Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the EBS balance sheet.
- There are more short-term assets than long-term liabilities on the EBS balance sheet.
- EBS profit margin has gone up from -18.6% to 9.6% in the past year.
Failed Health Checks:
- EBS earnings of $165.30M is not sufficient to cover its interest payments.
- EBS's operating cash flow of $13.00M allows it to safely service it's debt of $663.10M.
- EBS has a relatively high debt to equity ratio of 1.51.
- Total EBS debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy EBS stock, according to analysts?
Out of 1 Equities analysts who give forecasts on EBS, the consensus analyst rating on Emergent Biosolutions is a Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Emergent Biosolutions stock forecast page.
EBS Technical Indicators
EBS Growth Numbers
Last year, EBS earnings were $75.90M. Over the last 5 year, EBS's earnings have gone up by -14.89% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 3.93%.
Last year, EBS revenue was $788.90M. During the last five year, EBS's revenue has increased by -9.96% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 7.8%.
Dig into EBS's earnings and revenue performance here.
Who is buying/selling EBS?
In the past 12 months, executives and large shareholders at EBS have sold more shares than they have bought.
Simon C. Lowry, SVP RD CMO of EBS, was the latest EBS insider to sell. They sold $40,425.63 worth of EBS stock on Dec 14, 2025.
Research more about who owns EBS shares here.
Does EBS provide a stable income stream?
No, Emergent Biosolutions doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your EBS purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount, use a limit order.
Click the Open button and eToro will execute the order.
If you want more assistance investing in stocks on eToro, watch the how to video below:
Step 6: Watch your investment in EBS
Now that you own some EBS shares, you'll want to stay up-to-date on your new investment.
Start a watchlist to get the latest updates about your EBS stock.
EBS Feed
How to Buy Stock in Emergent Biosolutions
To summarize, here are the 6 steps for buying Emergent Biosolutions stock:
- Figure out where to buy Emergent Biosolutions stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Evaluate Emergent Biosolutions stock
- Place your EBS purchase
- Watch your investment in EBS
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to track your investment in Emergent Biosolutions, add EBS to your watchlist by clicking the button below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.